Business
Bio Spectrum
“The N-FIS market is no longer emerging; it's aligning with where healthcare is headed”
Once viewed as a niche innovation, Needle-Free Injection System (N-FIS) are now evolving into a multi-therapy drug delivery solution, with growing applications across paediatrics, vaccination, in vitro fertilisation (IVF), pain management, and the rapidly expanding GLP-1 therapy segment.
5 min |
July 2026
Bio Spectrum
Imaging Endpoints appoints Srikanth Ayyappan as AVP, Global Marketing
Imaging Endpoints, a Hyderabad-based oncologyfocused imaging contract research organisation (CRO), has appointed Srikanth Ayyappan as Associate Vice President (AVP), Global Marketing.
1 min |
July 2026
Bio Spectrum
Cytiva introduces next-gen Biacore 8 series SPR systems for drug discovery
US-based Cytiva, a Danaher company, is introducing the next generation of its Biacore 8 series SPR systems, enabling scientists to generate reliable interaction data faster, as drug discovery grows more complex.
1 min |
July 2026
Bio Spectrum
Decentralization and Fragmentation in Bioprocessing Industry
The global bioprocessing industry is undergoing a fundamental transformation.
2 min |
July 2026
Bio Spectrum
Vijay TS steps in as CPO at Redcliffe Labs
Noida-based Redcliffe Labs has announced the appointment of Vijay T. S. as Chief People Officer (CPO), as the company continues to strengthen its organisational foundation to support its next phase of growth and expansion across India.
1 min |
July 2026
Bio Spectrum
Dr Sanjay Chaturvedi takes charge as CEO at Matrix Pharmacorn
Telangana-based Matrix Pharmacorp has announced the appointment of Dr Sanjay Chaturvedi as Chief Executive Officer (CEO).
1 min |
July 2026
Bio Spectrum
How Mergers and Acquisitions Spell Success for Pharma Companies
The recent acquisition of Organon by Sun Pharmaceutical Industries marks one of the largest pharmaceutical deals involving an Indian company. The all-cash transaction, valued at approximately $11.75 billion, highlights the growing global ambitions of Indian pharmaceutical firms. The latest mergers and acquisitions (M&A) have emerged as a strategic tool for pharmaceutical companies to strengthen market presence, what the future holds and the associated risks. However, challenges remain. Let us delve deep into what goes into these huge M&A transactions and what can be the likely challenges.
6 min |
July 2026
Bio Spectrum
Align Technology to open multi-million dollar manufacturing facility in Hyderabad
Align Technology, Inc., a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero intraoral scanners and services, and exocad CAD/ CAM software for digital orthodontics and restorative dentistry, has announced plans to open a new manufacturing facility in Hyderabad, in 2027, create more than 300 direct jobs, and spend approximately $200 million in both capital and operational expense over the next several years.
1 min |
July 2026
Bio Spectrum
Pharma Fermentation: India's Next Biomanufacturing Opportunity
Driven by increasing demand for biologics, antibiotics, enzymes, biosimilars, and services offered by Contract Development and Manufacturing Organisations (CDMOs) and Contract Research Development and Manufacturing Organisations (CRDMOs), the Indian pharmaceutical fermentation market is witnessing strong growth. The industry is gradually shifting from the production of traditional generic medicines toward higher-value, fermentation-based products, reflecting the growing importance of complex biologics and advanced therapeutics. According to IMARC Group, the India fermentation chemicals market reached $3.2 billion in 2025 and is projected to grow to $5.5 billion by 2034, exhibiting a CAGR of 5.79 per cent during 2026-2034. However, growth alone will not guarantee leadership. India’s ability to build a robust domestic fermentation ecosystem, reduce import dependence, and scale advanced biomanufacturing capabilities will determine whether it can emerge as a global fermentation hub. Let's explore further.
7 min |
July 2026
Bio Spectrum
GVRP & StepsBio unveil new formulations R&D centre in Bengaluru
GVRP (GV Research Platform), a Hyderabadbased research organisation, has announced the inauguration of the GVRP Steps Bio Research Centre (GSRC), a strategic collaboration with Bengalurubased startup Steps Biosciences that marks a significant milestone in India's pharmaceutical R&D landscape.
1 min |
July 2026
Bio Spectrum
Alembic Pharma ropes in Ramesh Juneja as EVP Human Health -
Vadodara-based Alembic Pharmaceuticals has announced the appointment of Ramesh Juneja as Executive Vice President (EVP) - Human Health (Sales and Marketing), for its India business.
1 min |
July 2026
Bio Spectrum
“Gaps like limited fast-track approval pathways, pricing regulations that may constrain R&D incentives continue to pose challenges”
As biologics, cell and gene therapies, and precision medicine reshape the global healthcare landscape, Asia-Pacific is emerging as a strategic hub for biopharmaceutical manufacturing and innovation.
5 min |
July 2026
Bio Spectrum
Bruker announces major strides in 4D proteomics performance
Bruker Corporation has announced the launch of the unique timsMRMS system, bringing the power of trapped ion mobility separation to ultra-highresolution magnetic resonance mass spectrometry (MRMS).
1 min |
July 2026
Bio Spectrum
Generics to Global Innovation Powerhouse
India's target is to achieve a $450 billion share in global pharmaceutical trade by 2047.
2 min |
July 2026
Bio Spectrum
Dr Abhay Karandikar relinquishes role as DST Secretary
Dr Abhay Karandikar, serving as the Secretary, Department of Science of Technology (DST) since October 2023, has moved out to become a full-time member at NITI Aayog.
1 min |
July 2026
Bio Spectrum
Why India’s Next Healthcare Shift Will Be Decentralised by Design
Diagnostics has historically sat at the centre of clinical decision-making, yet operationally it has remained distant from where care actually begins. In India, this structural mismatch is becoming increasingly difficult to ignore. Let's take a deep dive and unearth what's the growing trend and initiatives.
4 min |
July 2026
Bio Spectrum
BIOCATALYST LEADERSHIP: How Enzymes are Propelling India's Pharma
As silent workhorses of the pharmaceutical industry, enzymes are playing an increasingly important role in shaping how modern medicines are discovered and manufactured.
8 min |
July 2026
Bio Spectrum
Amity University inks MoA with Quaraxia Pharma to strengthen biotech and biopharma research
Amity University, Uttar Pradesh has signed a Memorandum of Agreement (MoA) with Muzaffarnagar-based Quaraxia Pharmaceuticals to promote industryacademia collaboration in the fields of biotechnology and biopharma research.
1 min |
July 2026
Bio Spectrum
Archimedis Digital strengthens focus on advanced AI-led innovation with $2 M investment
Chennai-based Archimedis Digital, a life sciences-focused technology company, is strengthening its focus on advanced artificial intelligence (AI)-led innovation with a committed investment of $2 million.
1 min |
July 2026
Bio Spectrum
Hinduja Foundation, King's College London announce 2026 healthcare scholarship
Hinduja Foundation, the philanthropic arm of the Mumbaibased Hinduja Group, has announced scholarships 2026 for Indian origin students to pursue the MSc in MedTech Innovation & Entrepreneurship at King's College London.
1 min |
July 2026
Bio Spectrum
MediElaj raises $100K to bring Al-powered healthcare kiosks to underserved regions
India's healthcare technology landscape has taken a significant step forward with the official launch of MediElaj, an artificial intelligence (AI)-powered healthcare app and smart diagnostic kiosk and mobile app platform developed by MedPredict.
1 min |
July 2026
Bio Spectrum
Qiagen connects AI-driven scientific guidance across Sample to Insight workflows
Qiagen announced the global launch of QIA Agent, an artificial intelligence (AI)-powered digital assistant designed to simplify how researchers plan experiments, identify suitable products, access technical information and manage ordering support through a single conversational interface.
1 min |
July 2026
Bio Spectrum
ICMR releases comprehensive guidelines for establishment of biorepositories
The Indian Council of Medical Research (ICMR) has released comprehensive guidelines to create a harmonised framework for biorepository governance across its institutes, building on the wide range of biological specimens available nationwide.
1 min |
July 2026
Bio Spectrum
Poly Medicure names Indranil Mukherjee as CEO, Asia Pacific and India
Poly Medicure, a Delhi-based medical device company with a dominant position in the medical consumables market, has announced the appointment of Indranil Mukherjee as Chief Executive Officer (CEO), Asia Pacific and India, effective June 1, 2026.
1 min |
July 2026
Bio Spectrum
Ending Hepatitis Scourge by 2030
According to the Global Hepatitis Report 2026, released ahead of the World Hepatitis Day (on July 28) by the World Health Organisation (WHO), the progress towards the global goal of eliminating viral hepatitis as a public health threat by 2030 is off track.
2 min |
July 2026
Bio Spectrum
India's Push for True Self-Reliance in Molecular Biology
Modern biotechnology's most visible achievements like diagnostic breakthroughs, genomic sequencing platforms, and biologic therapeutics, rest on a less visible but equally critical foundation: an extensive ecosystem of enzymes, reagents, and kits that supply research laboratories, diagnostic centres, pharmaceutical companies, and biotechnology firms.
6 min |
July 2026
Bio Spectrum
Wadhwani-IISc Innovation Centre to strengthen quantum and deep-tech innovation ecosystem
Bengaluru-based Indian Institute of Science (IISC) has marked a significant milestone in India's innovation journey with the recent inauguration of the Wadhwani-IISc Innovation Centre.
1 min |
July 2026
Bio Spectrum
Border Plus launches India's first national standardised exam for nurses seeking international careers
BorderPlus, a Mumbai-based global talent mobility platform, has announced the launch of B.R.I.D.G.E (Border Plus International Deployment and Global Mobility Exam), the country's first standardised national examination designed to assess and prepare Indian nurses for international placement, with a primary focus on career opportunities abroad. B.R.I.D.G.E introduces a merit-based scholarship model with a total pool worth Rs 1 crore+, designed to directly reduce the cost of training the nurses are required to undergo to upskill themselves for an international career.
1 min |
July 2026
Bio Spectrum
“Biosuppliers must invest not only in scientific capability but also in green infrastructure and transparent reporting”
India's rapidly expanding life sciences ecosystem is driving increasing demand for laboratory automation, as pharmaceutical companies, CRDMOs, biotechnology firms and research institutions seek to improve efficiency, scalability and reproducibility.
4 min |
July 2026
Bio Spectrum
ISIC Multispeciality Hospital & DrRing launch integrated wearable emergency response device
Indian Spinal Injuries Centre (ISIC) Multispeciality Hospital has partnered with Delhi-based startup DrRing to launch India's first hospital-integrated wearable emergency response device directly connected to a hospital emergency department.
1 min |